Results 211 to 220 of about 208,828 (307)

Acquired vulnerability against EGF receptor inhibition in gastric cancer promoted by class I histone deacetylase inhibitor entinostat. [PDF]

Neoplasia
Zenz T, Jenke R, Oliinyk D, Noske S, Thieme R, Kahl T, Gockel I, Meier-Rosar F, Aigner A, Büch TR.   +9 more
europepmc   +1 more source

Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation

Proceedings of the National Academy of Sciences of the United States of America, 2003
S. Haggarty, K. M. Koeller, Jason C. Wong, C. Grozinger, S. Schreiber   +4 more
semanticscholar   +1 more source

Preconditioning of Human Umbilical Cord Mesenchymal Stem Cells with a Histone Deacetylase Inhibitor: Valproic Acid. [PDF]

Balkan Med J
Işıldar B, Özkan S, Koyutürk M.
europepmc   +1 more source

Effect of histone deacetylase and proteasome inhibitors in glioma models

Luciana; id_orcid 0000-0002-2306-7959 Costa Furtado, Frank; id_orcid 0000-0002-2445-9380 Kruyt, Leticia Veras Costa-Lotufo   +2 more
openalex   +1 more source

Molecular design, synthesis and simulation of histone deacetylase inhibitors [PDF]

, 2010
暁暉 李
openalex  

Development of a histone deacetylase 6 inhibitor and its biological effects

Proceedings of the National Academy of Sciences of the United States of America, 2013
Ju-Hee Lee, Adaickapillai Mahendran, Yuanshan Yao, L. Ngo, G. Venta-Perez, M. L. Choy, Nathaniel Kim, W. Ham, R. Breslow, P. Marks   +9 more
semanticscholar   +1 more source

Safety, pharmacokinetics, and efficacy of abexinostat, an novel histone deacetylase inhibitor, in Chinese patients with relapsed/refractory B cell non-Hodgkin lymphoma: a Phase 1 study. [PDF]

BMC Cancer
Gui L, Xie Z, Qin Y, Liu P, Yang J, Chen X, Li Z, Tao R, Shi Y.   +8 more
europepmc   +1 more source

Overcoming reduced glucocorticoid sensitivity in airway disease:molecular mechanisms and therapeutic approaches [PDF]

, 2010
Abraham, Adcock, Ali, Allfrey, Auphan, Barnes, Barnes, Barnes, Barnes, Bartholome, Bartling, Bartling, Bateman, Beesley, Bergeron, Bhavsar, Bhavsar, Bourbeau, Cai, Calverley, Carmichael, Carrabino, Charmandari, Chen, Cho, Chung, Chung, Chung, Ciencewicki, Condliffe, Cosio, Cosio, Culpitt, Culpitt, Denslow, Duma, Evans, Ferreira, Fitzpatrick, Freedman, Gagliardo, Galasinski, Galliher-Beckley, Galliher-Beckley, Goleva, Gross, Gross, Hakonarson, Haller, Hew, Hogg, Hwang, Ian M. Adcock, Irusen, Ito, Ito, Ito, Ito, Ito, Ito, Jatakanon, John, John A. Marwick, Karp, Keatings, Kian Fan Chung, King, Kino, Kitagawa, Kleiman, Knoepfler, Konstan, Korn, Kovacs, Krstic, Kumar, Kumar, Kurashima, Laffargue, Langhoff, Lee, Lee, Lewis-Tuffin, Li, Li, Liu, Lu, Macedo, Mak, Mannino, Marone, Marwick, Marwick, Marwick, Marwick, Marwick, Matysiak, Meagher, Medicherla, Meja, Miller, Molnarfi, Moore, Murphy, Muselet-Charlier, Onda, Osoata, OʼSullivan, Pace, Patel, Pratt, Pujols, Pujols, Rahman, Rahman, Raia, Reichardt, Renda, Rennard, Rhen, Rogatsky, Rommel, Rottner, Rumora, Saccani, Sadhu, Sasaki, Schacke, Scheinman, Schermer, Sethi, Silverstein, Smith, Smolonska, Stav, Strickland, Suissa, Szatmuíry, Thomson, Tomlinson, Tuckermann, Tudhope, Ukena, Usmani, van Rensen, Verhaeghe, Ward, Ward, Wood, Wright, Young   +150 more
core   +1 more source

Identification of a histone deacetylase inhibitor as a therapeutic candidate for congenital central hypoventilation syndrome. [PDF]

Mol Ther Nucleic Acids
Africano C, Bachetti T, Uva P, Pitollat G, Del Zotto G, Giacopelli F, Recchi G, Lenfant N, Madani A, Beckouche N, Thoby-Brisson M, Ceccherini I.   +11 more
europepmc   +1 more source

Deacetylase inhibitors - focus on non-histone targets and effects

, 2010
Matthias Ocker
openalex   +2 more sources